Day: November 29, 2023

Figure 1Plan view of the Chelopech mining concession, Chelopech North Commercial Discovery and Brevene exploration licences, indicating target zones for DPM’s 2024 in-mine and brownfield exploration program as well as the section line (A-A’) shown in Figure 2.Figure 2Long-section (A-A’) through Sharlo Dere looking northwest, displaying drilling intercepts, interpreted geology, and exploration targets.Figure 3Photographs of representative high-grade copper-gold mineralized drill core from hole EX_SD_27 at the Sharlo Dere zone.(All monetary figures in this news release are expressed in U.S. dollars unless otherwise stated) TORONTO, Nov. 29, 2023 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) is pleased to provide an interim update to the Mineral Resource and Mineral Reserve...

Sisecam, a global player in the fields of glass and chemicals, is celebrating its 88th year anniversarySisecam 88th AnniversarySisecam 88th AnniversaryISTANBUL, Turkey, Nov. 29, 2023 (GLOBE NEWSWIRE) — Sisecam, a global player in the fields of glass and chemicals, is celebrating its 88th year anniversary. Inspired by the visionary leadership of Mustafa Kemal Atatürk, who founded Sisecam, the company leads its industries with innovation and unity striving to excel and make a positive impact every day. The company started its growth journey with a single facility in Turkey and 400 employees in 1935. Today, Sisecam is a global pioneer that operates production facilities in 14 countries with a sales network of 150 countries and more than 25,000 employees. As the only global company operating in all core areas of glass, Sisecam’s...

Revenues of $2.5M, up 25% over the last two quarters of the year; Gross margin of 18.6%, up sharply on last year’s negative gross margin of (1%); Adjusted EBITDA1 of $0.1M compared with negative adjusted EBITDA of $0.9M a year earlier; Projected sequential revenue growth for Q4-23 in excess of 40%; From early 2024, the Company will take advantage of new agreements unveiled last October for purchase orders worth up to $2.6 million per year for natural health products, bringing its current order book in excess of $6 million; Temporary authorization from the U.S. Food and Drug Administration (FDA) to export its ErythromycinPr ophthalmic ointment.BOUCHERVILLE, Quebec, Nov. 29, 2023 (GLOBE NEWSWIRE) — LSL PHARMA GROUP INC (TSXV: LSL) – LSL Pharma Group Inc. (“the Company” or “LSL Pharma Group”),...

CHICAGO and VANCOUVER, British Columbia, Nov. 29, 2023 (GLOBE NEWSWIRE) — RISE Dispensaries, a rapidly growing cannabis retail chain owned by Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), today announced that it will open two RISE Dispensaries in Florida, with one located in Tampa and the other located in Crystal River, on December 1. These store openings bring the Company’s retail footprint to 13 in Florida and 89 nationwide. RISE Dispensary Tampa will host a grand opening celebration on December 16, where profits from the day will be donated to Tu Canna Foundation. RISE Dispensary Crystal River will host a grand opening celebration on December 15, with profits benefitting The Bridge 4 Veterans. “We are extremely excited to deepen our presence on the west coast of Florida with two new...

Company Presentation to highlight novel therapeutic candidates targeting the HGF neurotrophic system in late-stage clinical development in neurodegenerative diseases, including Alzheimer’s disease BOTHELL, Wash., Nov. 29, 2023 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in the Sidoti December Small Cap Conference, taking place virtually from December 6-7, 2023. Details are as follows: Sidoti December Small Cap ConferenceFormat: Company PresentationDate and Time: Wednesday, December 6, 2023, from 12:15 pm – 12:45 pm EST Location: Virtual A live webcast of the presentation can be accessed from the Investors section of...

RESEARCH TRIANGLE PARK, N.C., Nov. 29, 2023 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the National Administration of Drugs, Foods, and Medical Devices (ANMAT) in Argentina has granted approval for oral, once-daily ORLADEYO® (berotralstat) for the prophylaxis of hereditary angioedema (HAE) attacks in adults and pediatric patients 12 years of age or older. “We continue to make strides to bring ORLADEYO to patients living with HAE in Latin America in collaboration with our partner, Pint Pharma. We applaud ANMAT’s decision to grant approval to our oral, once-daily prophylactic therapy for HAE, which paves the way for patients living with HAE to receive ORLADEYO to help improve management of their HAE attacks,” said Charlie Gayer, chief commercial officer of BioCryst. BioCryst has an exclusive...

ROAD TOWN, British Virgin Islands, Nov. 29, 2023 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: ORAAF) (“Aura” or the “Company”) announced today that the Company’s Board of Directors (the “Board”) has declared and approved the payment of a dividend (the “Dividend”) of US$0.25 per common share (approximately US$18 million in total). In accordance with the Company’s dividend policy (the “Dividend Policy”), the Dividend is in respect of and is based on Aura’s expected financial results for the six months ending on December 31, 2023. Under the Dividend Policy, the Company’s annual dividend is equal to 20% of its estimated Adjusted EBITDA1 for the relevant six months less sustaining capital expenditures and exploration capital expenditures for the same period. The amount of the Dividend is based on the actual...